CPM
Welcome to the Center for Predictive Medicine for Biodefense
and Emerging Infectious Diseases!
Colleen B. Jonsson, Ph.D.
Director
Professor of Microbiology
Newly emerging and re-emerging pathogens and the diseases they cause pose a serious threat to all of us, whether they arise from nature or intentional sources. The mission of Center for Predictive Medicine for Biodefense and Emerging Infectious Disease (CPM) is to support basic and translational research to promote understanding of these pathogens and their diseases for the development of therapeutics. Hence our mission is for you, your family, our community, and our society to discover and develop treatments for newly emerging pathogens and keep our community safe.
The research efforts of the faculty, fellows, graduate students and staff affiliated with the CPM will provide new insights into basic mechanisms of newly recognized emerging diseases such as the “swine flu”, West Nile encephalitis, hantavirus pulmonary syndrome and SARS. We are committed to translation of our basic research efforts into new diagnostic methods, antivirals, antimicrobial drugs, and vaccines. For the conduct of these research and development efforts, the University of Louisville was awarded a grant to construct one of eleven Regional Biocontainment Laboratories (RBL) funded by the National Institutes of Health to provide state-of-the-art containment of these pathogens. The new laboratory will play a key role in economic development. It will create jobs, employ more people in the high-tech sector and offer training that students can take to the workforce. New discoveries such as diagnostic tools, drugs and vaccines could lead to the creation of new locally based technology companies.
News
Resources
